These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 11064479

  • 1. Fludarabine therapy in chronic lymphocytic leukemia-associated severe nephrotic syndrome.
    Abdel-Raheem MM, Jamil MG, Potti A, Gross GG.
    Haematologica; 2000 Nov; 85(11):1224-5. PubMed ID: 11064479
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Fludarabine in chronic lymphocytic leukemia with membranous nephropathy.
    Rocca AR, Giannakakis C, Serriello I, Guido G, Mosillo G, Salviani C.
    Ren Fail; 2013 Nov; 35(2):282-5. PubMed ID: 23176062
    [Abstract] [Full Text] [Related]

  • 5. Fludarabine for chronic lymphocytic leukemia.
    Erman M, Celik I, Tekuzman G.
    N Engl J Med; 2001 Apr 12; 344(15):1166; author reply 1167-8. PubMed ID: 11302142
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Nephrotic syndrome associated with chronic lymphocytic leukemia resistant to immunosuppressive drugs: remission obtained by splenectomy.
    Halimi JM, Lavabre-Bertrand T, Beraud JJ, Canaud B.
    Clin Nephrol; 1996 Apr 12; 45(4):273-6. PubMed ID: 8861805
    [Abstract] [Full Text] [Related]

  • 8. Fludarabine for chronic lymphocytic leukemia.
    Copur MS, Ledakis P, Muhvic J.
    N Engl J Med; 2001 Apr 12; 344(15):1166; author reply 1167-8. PubMed ID: 11302141
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. High-dose methylprednisolone can induce remissions in patients with fludarabine-refractory chronic lymphocytic leukaemia.
    Xu W, Miao KR, Hong M, Zhu DX, Fang C, Dong HJ, Wang DM, Cao X, Li JY.
    Eur J Cancer; 2010 Aug 12; 46(12):2145-9. PubMed ID: 20627536
    [Abstract] [Full Text] [Related]

  • 11. [Fludarabine treatment of chronic lymphoid leukemia].
    Gabeeva NG, Pivnik AV, Moiseeva TN, Zybunova EE, Samoĭlova RS, Kremenetskaia AM, Varlamova EIu, Kaplanskaia IB.
    Ter Arkh; 2000 Aug 12; 72(8):42-5. PubMed ID: 11019427
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tumor lysis syndrome associated with fludarabine treatment in chronic lymphocytic leukemia.
    Dizdar O, Yürekli BS, Pürnak T, Aksu S, Haznedaroglu IC.
    Ann Pharmacother; 2004 Aug 12; 38(7-8):1319-20. PubMed ID: 15138295
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Severe autoimmune hemolytic anemia following fludarabine therapy in a patient with chronic lymphocytic leukemia.
    Tsiara S, Christou L, Konstantinidou P, Panteli A, Briasoulis E, Bourantas KL.
    Am J Hematol; 1997 Apr 12; 54(4):342. PubMed ID: 9092698
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Acute tumor lysis syndrome during oral fludarabine treatment for CLL--a rare event that might be observed more frequently in the future.
    Rioufol C, Coiffier B.
    Onkologie; 2008 Apr 12; 31(4):157-8. PubMed ID: 18418014
    [No Abstract] [Full Text] [Related]

  • 20. Fludarabine approved for use in chronic lymphocytic leukemia.
    Oncology (Williston Park); 1991 Jun 12; 5(6):20. PubMed ID: 1831638
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.